Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase
NCT03856203 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2023-11-18
Summary
Conduct a prospective, longitudinal study to evaluate nutritional status in adults with phenylketonuria (PKU) before and during treatment with pegvaliase (Palynziq™).
Conditions
- Phenylketonurias
Sponsors & Collaborators
- collaborator INDUSTRY
- lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-08
- Primary Completion
- 2022-12-31
- Completion
- 2023-10-20
Countries
- United States
Study Locations
More Related Trials
-
A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults
NCT03505125 ·Status: COMPLETED
-
A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding
NCT05579548 ·Status: RECRUITING
-
Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria
NCT05270837 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers
NCT07220265 ·Status: RECRUITING ·Phase: NA
-
A Prospective Clinical Study of Phenylketonuria (PKU)
NCT04452513 ·Status: COMPLETED
-
Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)
NCT00924703 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, and Efficacy Study of rAvPAL-PEG Administered Daily in Subjects With Phenylketonuria (PKU)
NCT01212744 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks
NCT01560286 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
NCT01889862 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
NCT00634660 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria
NCT06147856 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.
NCT05827536 ·Status: TERMINATED ·Phase: NA
-
Natural History Clinical Study in Adult PKU
NCT04768348 ·Status: TERMINATED
-
Neurocognitive Outcomes in Mild Hyperphenylalaninemia (MHP)MHP Study
NCT01924026 ·Status: COMPLETED
-
Pyruvate Kinase Deficiency Natural History Study
NCT02053480 ·Status: COMPLETED
-
Betaine and Peroxisome Biogenesis Disorders
NCT01838941 ·Status: COMPLETED ·Phase: PHASE3
-
Antioxidant Signature in Adult Patients With Phenylketonuria
NCT02212288 ·Status: COMPLETED
-
Gene Therapy Clinical Study in Adult PKU
NCT03952156 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
AAV Gene Therapy Study for Subjects with PKU
NCT04480567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia
NCT03167697 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Phe Fluctuation in PKU Pts Treated With PKU GOLIKE Versus Standard Amino Acid Protein Substitute.
NCT05487378 ·Status: COMPLETED ·Phase: NA
-
A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels
NCT00225615 ·Status: COMPLETED ·Phase: PHASE3
-
Nutritional Status in Phenylketonuria
NCT03820804 ·Status: COMPLETED
-
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
NCT04706013 ·Status: RECRUITING ·Phase: PHASE3
-
An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165
NCT01819727 ·Status: COMPLETED ·Phase: PHASE3